ArticleJournal of the neurological sciences2020
Myasthenic crisis in COVID-19.
Article in Journal of the neurological sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.
- Characteristics, treatment, and outcomes of Myasthenia Gravis in COVID-19 patients: A systematic review.Clinical neurology and neurosurgery · 2022Pooled it
- Possible involvement of viral infection in the pathogenesis of myasthenia gravis.Journal of neurovirology · 2026Review
- Predictive Factors for Poor Outcomes Associated with COVID-19 in a Retrospective Cohort of Myasthenia Gravis Patients.Journal of inflammation research · 2024Article
- Better safe than sorry-Whole-genome sequencing indicates that missense variants are significant in susceptibility to COVID-19.PloS one · 2023Article
- Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review.Frontiers in neuroscience · 2023Review
- Inflammation and autoimmune myasthenia gravis.Frontiers in immunology · 2023Review
- BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves.Journal of neurology · 2022Article
- A Case Report and Literature Review of New-Onset Myasthenia Gravis After COVID-19 Infection.Cureus · 2022Article
- COVID-19 and myasthenia gravis: A review of neurological implications of the SARS-COV-2.Brain and behavior · 2022Review
- Acute neuromuscular syndromes with respiratory failure during COVID-19 pandemic: Where we stand and challenges ahead.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2022Review
- New-onset myasthenia gravis after novel coronavirus 2019 infection.Respirology case reports · 2022Article
- Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID-19.Muscle & nerve · 2022Article
- Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al.Acta neurologica Belgica · 2022Article
- Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis.Neuromuscular disorders : NMD · 2022Article
- Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2022Article
- Impact of COVID-19 infection among myasthenia gravis patients- a Cerner Real-World DataBMC neurology · 2022Article
- Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality.International reviews of immunology · 2022Article
- The changes in psychological symptoms of COVID-19 patients after "re-positive".Frontiers in psychiatry · 2022Article
- An Overview of Neurological and Psychiatric Complications During Post-COVID Period: A Narrative Review.Journal of inflammation research · 2022Review
- COVID-19 Outcomes in Myasthenia Gravis Patients: Analysis From Electronic Health Records in the United States.Frontiers in neurology · 2022Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Comment on
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.